, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
+49 89 9399 6237 info(at)shodex.de Konrad-Zuse-Platz 3, Munich Mo-Thu 8:30 - 17:00 / Fr 8:30 - 16:00
Konrad-Zuse-Platz 3, Munich   

Analysis of Purified Sodium Hyaluronate Ophthalmic Solution According to JP Method (SB-802.5 HQ)

Print
According to the Japanese Pharmacopeia (JP; 17th edition*), analysis of purified sodium hyaluronate ophthalmic solution should meets following requirements. The OHpak SB-802.5 HQ confirmed the requirements were met.

System suitability requirements:
   Resolution of Hyaluronic acid /ε-Aminocaproic acid: ≥ 5
   Relative standard deviation (RSD) of six analyses: ≤ 2.0%

*The version at the time of the application acquisition.


Sample : 20 μL
System suitability solution (prepared according to JP method)
1. Hyaluronic acid
2. ε-Aminocaproic acid
Column       : Shodex OHpak SB-802.5 HQ (8.0 mm I.D. x 300 mm)
Eluent       : 0.1 M Na2SO4 aq.
Flow rate    : 1.0 mL/min
Detector     : UV (210 nm)
Column temp. : 40 °C